Michael Haake, MD
Radiation Oncology · Charlotte, NCNPI 1760441703
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Immunocore Limited at 32.2% of the total. Reporting peaked in 2023 at $229 and has fallen 69.3% since, to $70 in 2024.
Across 18 payments — averaging $26.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Immunocore Limited$153
- Lilly USA, LLC$38
- AstraZeneca$37
- Sanofi$36
- Johnson & Johnson$36
- Eisai Inc.$31
- plus $145 from 7 others
What the payments were for
- Food & beverage$476100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Immunocore Limited | 1 | $153 |
| Lilly USA, LLC | 2 | $38 |
| AstraZeneca | 2 | $37 |
| Sanofi | 2 | $36 |
| Johnson & Johnson | 2 | $36 |
| Eisai Inc. | 2 | $31 |
| Pfizer | 1 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Genmab U.S., Inc. | 1 | $21 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $19 |
| Servier Pharmaceuticals LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KIMMTRAK$153
How this compares
$476 in reported general payments places this provider in the 55th percentile of 199 radiation oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Charlotte
- John HeinzerlingCharlotte$29K
- Stuart BurriCharlotte$17K
- Michael LecompteCharlotte$9K
- Roshan PrabhuCharlotte$6K
- Matthew WardCharlotte$3K
- Andrew WangChapel Hill$118K
- Volker StieberWinston Salem$99K
- Lewis SulmanDurham$54K
- Michael PapagikosWilmington$51K
- William LeeDurham$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.